Refine
Has Fulltext
- yes (1054)
Year of publication
- 2022 (1054) (remove)
Document Type
- Journal article (810)
- Doctoral Thesis (199)
- Working Paper (17)
- Book article / Book chapter (12)
- Preprint (4)
- Report (3)
- Book (2)
- Master Thesis (2)
- Review (2)
- Bachelor Thesis (1)
Language
- English (1054) (remove)
Keywords
- COVID-19 (16)
- Datennetz (14)
- SARS-CoV-2 (11)
- machine learning (11)
- virtual reality (11)
- heart failure (10)
- prostate cancer (10)
- inflammation (9)
- remote sensing (9)
- 3D printing (8)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (130)
- Graduate School of Life Sciences (79)
- Institut für Informatik (66)
- Medizinische Klinik und Poliklinik I (56)
- Neurologische Klinik und Poliklinik (54)
- Medizinische Klinik und Poliklinik II (50)
- Institut für Geographie und Geologie (48)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (44)
- Institut für Organische Chemie (41)
- Institut für Psychologie (39)
Schriftenreihe
Sonstige beteiligte Institutionen
- IZKF Nachwuchsgruppe Geweberegeneration für muskuloskelettale Erkrankungen (5)
- Bernhard-Heine-Centrum für Bewegungsforschung (4)
- Zentraleinheit Klinische Massenspektrometrie (3)
- Fraunhofer-Institut für Silicatforschung ISC (2)
- Helmholtz Institute for RNA-based Infection Research (HIRI) (2)
- Krankenhaushygiene und Antimicrobial Stewardship (Universitätsklinikum) (2)
- Wilhelm-Conrad-Röntgen-Forschungszentrum für komplexe Materialsysteme (2)
- ALPARC - The Alpine Network of Protected Areas (1)
- Albert-Ludwigs-Universität Freiburg (1)
- Arizona State University, Tempe, Arizona, USA (1)
Estrogens, namely 17β-estradiol (E2) and estrone (E1) are considered to play an important role in the initiation and promotion of breast cancer (summarized in Raftogianis et al., 2000), a malignancy responsible for around 500,000 deaths per year (summarized in Ghislain et al., 2016). Two major mechanisms have been postulated to explain the carcinogenic effects of estrogens: (1) the estrogen receptor-mediated stimulation of breast cell proliferation with a concomitant enhanced rate of mutations and (2) the metabolism of hydroxylated estrogens to quinone derivatives which can react with the DNA (Russo and Russo, 2006, summarized in Yager and Davidson, 2006). Nevertheless, as a detoxifying mechanism, E1, E2, and their hydroxylated and methoxylated metabolites are reversibly conjugated into sulfates and glucuronides devoid of biological activity (summarized in Guillemette et al., 2004). Yet, despite the key detoxifying function of these conjugates, the study of their circulating levels face some significant problems: (1) analysis by techniques such as radioimmunoassay lack specificity and accuracy and requires enzymatic/chemical hydrolysis before analysis, being unable to differentiate between sulfates and glucuronides (summarized in Stanczyk et al., 2007, summarized in Wang et al., 2016), (2) very little knowledge in healthy women, which has been identified as a barrier to advance in breast cancer research (summarized in Liu, 2000), and (3) far fewer studies in pre- than in postmenopausal women (summarized in Samavat and Kurzer, 2015). Therefore, to get more insights into the research of breast cancer etiology and prevention, the analysis of circulating levels of estrogens (including metabolites and conjugates) in women without breast cancer through reliable analytical techniques, is required.
One third of all market approved drugs target G protein coupled receptors (GPCRs), covering a highly diverse spectrum of indications reaching from acute anti-allergic treatment over bloodpressure regulation, Parkinson's disease, schizophrenia up to the treatment of severe pain. GPCRs are key signaling proteins that mostly function as monomers, but for several receptors constitutive dimer formation has been described and in some cases is essential for function. I have investigated this problem using the μ-opioid receptor (µOR) as a model system - based both on its pharmacological importance and on specific biochemical data suggesting that it may present a particularly intriguing case of mono- vs- dimerization. The µOR is the prime target for the treatment of severe pain. In its inactive conformation it crystallizes as homodimer when bound to the antagonist β- funaltrexamine (β-FNA), whereas the active, agonist-bound receptor crystallizes as a monomer. Using single-molecule microscopy combined with superresolution techniques on intact cells, I describe here a dynamic monomer-dimer equilibrium of µORs where dimer formation is driven by specific agonists. The agonist DAMGO, but not morphine, induces dimer formation in a process that correlates temporally and, in its agonist, and phosphorylation dependence with β-arrestin2 binding to the receptors. This dimerization is independent from but may precede µOR internalization. Furthermore, the results show that the μOR tends to stay, on the cell surface, within compartments defined by actin fibers and its mobility is modulated by receptor activation. These data suggest a new level of GPCR regulation that links receptor compartmentalization and dimer formation to specific agonists and their downstream signals.
Wilms tumor (WT) is the most common renal tumor in childhood. Among others, MYCN copy number gain and MYCN P44L and MAX R60Q mutations have been identified in WT. The proto-oncogene MYCN encodes a transcription factor that requires dimerization with MAX to activate transcription of numerous target genes. MYCN gain has been associated with adverse prognosis. The MYCN P44L and MAX R60Q mutations, located in either the transactivating or basic helix-loop-helix domain, respectively, are predicted to be damaging by different pathogenicity prediction tools. These mutations have been reported in several other cancers and remain to be functionally characterized.
In order to further describe these events in WT, we screened both mutations in a large cohort of unselected WT patients, to check for an association of the mutation status with certain histological or clinical features. MYCN P44L and MAX R60Q revealed frequencies of 3 % and 0.9 % and also were significantly associated to higher risk of relapse and metastasis, respectively. Furthermore, to get a better understanding of the MAX mutational landscape in WT, over 100 WT cases were analyzed by Sanger sequencing to identify other eventual MAX alterations in its coding sequence. R60Q remained the only MAX CDS alteration described in WT to date.
To analyze the potential functional consequences of these mutations, we used a doxycycline-inducible system to overexpress each mutant in HEK293 cells. This biochemical characterization identified a reduced transcriptional activation potential for MAX R60Q, while the MYCN P44L mutation did not change activation potential or protein stability. The protein interactome of N-MYC-P44L was likewise not altered as shown by mass spectrometric analyses of purified N-MYC complexes. However, we could identify a number of novel N-MYC partner proteins, several of these known for their oncogenic potential. Their correlated expression in WT samples suggested a role in WT oncogenesis and they expand the range of potential biomarkers for WT stratification and targeting, especially for high-risk WT.
The present work focusses on the borylation of aryl halides. The first chapter presents a detailed review about previously reported nickel-catalyzed borylation reactions. The second chapter of the thesis describes, the borylation reaction of C–Cl bonds in aryl chlorides mediated by an NHC-stabilized nickel catalyst. The cyclohexyl substituted NHC Cy2Im was used to synthesize novel Cy2Im-stabilized nickel complexes [Ni2(Cy2Im)4(μ-(η2:η2)-COD)] 1, [Ni(Cy2Im)2(η2-C2H4)] 2, and [Ni(Cy2Im)2(η2-COE)] 3. An optimized procedure was developed using 5 mol% of the Ni-catalyst, 1.5 equivalents of the boron reagent B2pin2, and 1.5 equivalents of NaOAc as the base in methylcyclohexane at 100 °C. With these optimized conditions, it was shown that a variety of aryl chlorides, containing either electron-withdrawing or -donating groups, were converted to the corresponding aryl boronic esters in yields up to 99% (88% isolated) yield. Mechanistic investigations revealed that the C–Cl oxidative addition product [Ni(Cy2Im)2(Cl)(4-F3C-C6H4)] 11, which has been synthesized and isolated separately, also catalyzes the reaction. Thus, rapid oxidative addition of the C–Cl bond of the aryl chloride to [Ni2(Cy2Im)4(μ-(η2:η2)-COD)] 1 to yield trans-[Ni(Cy2Im)2(Cl)(Ar)] represents the first step in the catalytic cycle. The rate limiting step in this catalytic cycle is the transmetalation of boron to nickel forming trans-[Ni(Cy2Im)2(Bpin)(Ar)], which was not possible to isolate. The boryl transfer reagent is assumed to be the anionic adduct Na[B2pin2(OAc)]. A final reductive elimination step gives the desired borylated product Ar–Bpin and regenerates [Ni(Cy2Im)2].
In the next chapter the first effective C–Cl bond borylation of aryl chlorides using NHC-stabilized Cu(I)-complexes of the type [Cu(NHC)(Cl)] was developed. The known complexes [Cu(iPr2Im)(Cl)] 15, [Cu(Me2ImMe)(Cl)] 16, and [Cu(Cy2Im)(Cl)] 17, bearing the small alkyl substituted NHCs, were synthesized in good yields by the reaction of copper(I) chloride with the corresponding free NHC at low temperature (-78 °C) in THF. A range of catalysts, bases, solvents, and boron sources were screened to determine the scope and limitations of this reaction. [Cu(Cy2Im)(Cl)] 17 revealed a significantly higher catalytic activity than [Cu(iPr2Im)(Cl)] 15. KOtBu turned out to be the only efficient base for this borylation reaction. Besides methylcyclohexane, toluene was the only solvent that gave the borylated product in moderate yields of 53%. It was shown that a variety of electron-rich and electron-poor aryl chlorides can be converted to the corresponding aryl boronic esters in isolated yields of up to 80%. A mechanism was proposed, in which a Cu-boryl complex [Cu(L)(Bpin)] is formed in the initial step. This is followed by C–B bond formation via σ-bond metathesis with the aryl chloride forming the aryl boronic ester and [Cu(L)(Cl)]. The latter reacts with KOtBu to give [Cu(L)(OtBu)], which regenerates the copper boryl complex by reaction with B2pin2.
Chapter 4 describes studies directed towards the transition metal-free borylation of aryl halides using Lewis base adducts of diborane(4) compounds. A variety of novel pyridine and NHC adducts of boron compounds were synthesized. Adducts of the type pyridine·B2cat2 18-19 and NHC·B2(OR)4 20-23 were examined for their ability to transfer a boryl moiety to an aryl iodide. However, only Me2ImMe∙B2pin2 20 was found to be effective. The stoichiometric reaction of 20 with different substituted aryl iodides and bromides in benzene, at elevated temperatures, gave the desired aryl boronic esters in good yields. Interestingly, depending on the reaction temperature, C–C coupling between the aryl halide and the solvent (benzene), was detected leading to a side product which, together with observed hydrodehalogenation of the aryl halide, provided indications that the reaction might be radical in nature.
When the boryl transfer reaction based on Me2ImMe∙B2pin2 20 was followed by EPR spectroscopy, a signal (though very weak and ill-defined) was detected, which is suggestive of a mechanism involving a boron-based radical. In addition, the boronium cation [(Me2ImMe)2∙Bpin]+ 37 with iodide as the counterion was isolated from the reaction residue, indicating the fate of the second boryl moiety. A preliminary mechanism for the boryl transfer from 20 to aryl iodides was proposed, which involves an NHC–Bpin˙ radical as the key intermediate. Me2ImMe–Bpin˙ is formed by homolytic B–B bond cleavage of the bis-NHC adduct (Me2ImMe)2∙B2pin2, which is formed in situ in small amounts under the reaction conditions. Me2ImMe–Bpin˙ reacts with the aryl iodide to give the aryl boronic ester with recovery of aromaticity. In the same step, from the second equivalent of NHC–Bpin˙, an NHC-stabilized iodo-Bpin adduct is formed as an intermediate, which is further coordinated by another NHC, yielding [(Me2ImMe)2∙Bpin]+I- 37.
Echolocation behavior, a navigation strategy based on acoustic signals, allows scientists to explore neural processing of behaviorally relevant stimuli. For the purpose of orientation, bats broadcast echolocation calls and extract spatial information from the echoes. Because bats control call emission and thus the availability of spatial information, the behavioral relevance of these signals is undiscussable. While most neurophysiological studies, conducted in the past, used synthesized acoustic stimuli that mimic portions of the echolocation signals, recent progress has been made to understand how naturalistic echolocation signals are encoded in the bat brain. Here, we review how does stimulus history affect neural processing, how spatial information from multiple objects and how echolocation signals embedded in a naturalistic, noisy environment are processed in the bat brain. We end our review by discussing the huge potential that state-of-the-art recording techniques provide to gain a more complete picture on the neuroethology of echolocation behavior.
Nonlimited proliferation is one of the most striking features of neoplastic cells. The basis of cell division is the sufficient presence of mass (amino acids) and energy (ATP and NADH). A sophisticated intracellular network permanently measures the mass and energy levels. Thus, in vivo restrictions in the form of amino acid, protein, or caloric restrictions strongly affect absolute lifespan and age-associated diseases such as cancer. The induction of permanent low energy metabolism (LEM) is essential in this process. The murine cell line L929 responds to methionine restriction (MetR) for a short time period with LEM at the metabolic level defined by a characteristic fingerprint consisting of the molecules acetoacetate, creatine, spermidine, GSSG, UDP-glucose, pantothenate, and ATP. Here, we used mass spectrometry (LC/MS) to investigate the influence of proliferation and contact inhibition on the energy status of cells. Interestingly, the energy status was essentially independent of proliferation or contact inhibition. LC/MS analyses showed that in full medium, the cells maintain active and energetic metabolism for optional proliferation. In contrast, MetR induced LEM independently of proliferation or contact inhibition. These results are important for cell behaviour under MetR and for the optional application of restrictions in cancer therapy.
The conspicuous colour sexual dimorphism of guppies has made them paradigmatic study objects for sex-linked traits and sex chromosome evolution. Both the X- and Y-chromosomes of the common guppy (Poecilia reticulata) are genetically active and homomorphic, with a large homologous part and a small sex specific region. This feature is considered to emulate the initial stage of sex chromosome evolution. A similar situation has been documented in the related Endler’s and Oropuche guppies (P. wingei, P. obscura) indicating a common origin of the Y in this group. A recent molecular study in the swamp guppy (Micropoecilia. picta) reported a low SNP density on the Y, indicating Y-chromosome deterioration. We performed a series of cytological studies on M. picta to show that the Y-chromosome is quite small compared to the X and has accumulated a high content of heterochromatin. Furthermore, the Y-chromosome stands out in displaying CpG clusters around the centromeric region. These cytological findings evidently illustrate that the Y-chromosome in M. picta is indeed highly degenerated. Immunostaining for SYCP3 and MLH1 in pachytene meiocytes revealed that a substantial part of the Y remains associated with the X. A specific MLH1 hotspot site was persistently marked at the distal end of the associated XY structure. These results unveil a landmark of a recombining pseudoautosomal region on the otherwise strongly degenerated Y chromosome of M. picta. Hormone treatments of females revealed that, unexpectedly, no sexually antagonistic color gene is Y-linked in M. picta. All these differences to the Poecilia group of guppies indicate that the trajectories associated with the evolution of sex chromosomes are not in parallel.
Pathological angiogenesis promotes tumor growth, metastasis, and atherosclerotic plaque rupture. Macrophages are key players in these processes. However, whether these macrophages differentiate from bone marrow-derived monocytes or from local vascular wall-resident stem and progenitor cells (VW-SCs) is an unresolved issue of angiogenesis. To answer this question, we analyzed vascular sprouting and alterations in aortic cell populations in mouse aortic ring assays (ARA). ARA culture leads to the generation of large numbers of macrophages, especially within the aortic adventitia. Using immunohistochemical fate-mapping and genetic in vivo-labeling approaches we show that 60% of these macrophages differentiate from bone marrow-independent Ly6c\(^{+}\)/Sca-1\(^{+}\) adventitial progenitor cells. Analysis of the NCX\(^{−/-}\) mouse model that genetically lacks embryonic circulation and yolk sac perfusion indicates that at least some of those progenitor cells arise yolk sac-independent. Macrophages represent the main source of VEGF in ARA that vice versa promotes the generation of additional macrophages thereby creating a pro-angiogenetic feedforward loop. Additionally, macrophage-derived VEGF activates CD34\(^{+}\) progenitor cells within the adventitial vasculogenic zone to differentiate into CD31\(^{+}\) endothelial cells. Consequently, depletion of macrophages and VEGFR2 antagonism drastically reduce vascular sprouting activity in ARA. In summary, we show that angiogenic activation induces differentiation of macrophages from bone marrow-derived as well as from bone marrow-independent VW-SCs. The latter ones are at least partially yolk sac-independent, too. Those VW-SC-derived macrophages critically contribute to angiogenesis, making them an attractive target to interfere with pathological angiogenesis in cancer and atherosclerosis as well as with regenerative angiogenesis in ischemic cardiovascular disorders.
Clostridioides difficile is a bacterial species well known for its ability to cause C. difficile
infection (also known as CDI). The investigation of the role of this species in the human
gut has been so far dominated by a disease-centred perspective, focused on studying
C. difficile in relation to its associated disease.
In this context, the first aim of this thesis was to combine publicly available
metagenomic data to analyse the microbial composition of stool samples from patients
diagnosed with CDI, with a particular focus on identifying a CDI-specific microbial
signature.
However, similarly to many other bacterial species inhabiting the human gut, C.
difficile association with disease is not valid in absolute terms, as C. difficile can be
found also among healthy subjects. Further aims of this thesis were to 1) identify
potential C. difficile reservoirs by screening a wide range of habitats, hosts, body sites
and age groups, and characterize the biotic context associated with C. difficile
presence, and 2) investigate C. difficile within-species diversity and its toxigenic
potential across different age groups.
The first part of the thesis starts with the description of the concepts and
definitions used to identify bacterial species and within-species diversity, and then
proceeds to provide an overview of the bacterial species at the centre of my
investigation, C. difficile. The first Chapter includes a detailed description of the
discovery, biology and physiology of this clinically relevant species, followed by an
overview of the diagnostic protocols used in the clinical setting to diagnose CDI.
The second part of the thesis describes the methodology used to investigate
the questions mentioned above, while the third part presents the results of such
investigative effort. I first show that C. difficile could be found in only a fraction of the
CDI samples and that simultaneous colonization of multiple enteropathogenic species
able to cause CDI-like clinical manifestations is more common than previously
thought, raising concerns about CDI overdiagnosis. I then show that the CDIassociated
gut microbiome is characterized by a specific microbial signature,
distinguishable from the community composition associated with non-CDI diarrhea.
Beyond the nosocomial and CDI context, I show that while rarely found in adults, C.
difficile is a common member of the infant gut microbiome, where its presence is
associated with multiple indicators typical of a desirable healthy microbiome
development.
In addition, I describe C. difficile extensive carriage among asymptomatic
subjects, of all age groups and a potentially novel clade of C. difficile identified
exclusively among infants.
Finally, I discuss the limitations, challenges and future perspectives of my
investigation.
G-protein-coupled receptors (GPCRs) are key biological switches that transmit both internal and external stimuli into the cell interior. Among the GPCRs, the “light receptor” rhodopsin has been shown to activate with a re-arrangement of the transmembrane helix bundle within ≈1 ms, while all other receptors are thought to become activated in subsecond range at saturating concentrations. Here we investigate activation kinetics of a dimeric GPCR, the metabotropic glutamate receptor-1 (mGluR1), and several class A GPCRs, as muscarinic receptor 3 (M3R), adrenergic (α2aAR and β1R) and opioid (µOR) receptors. We first used UV-light-triggered uncaging of glutamate in intact cells. Sub-millisecond Förster resonance energy transfer recordings between labels at intracellular receptor sites were used to record conformational changes in the mGluR1. At millimolar ligand concentrations the initial rearrangement between the mGluR1 subunits occurs at a speed of τ1≈1-2 ms. These rapid changes were followed by significantly slower conformational changes in the transmembrane domain (τ2≈20 ms). We further characterized novel photoswitchable negative allosteric modulators for mGluR1, which bind to its transmembrane core and block the conformational change as well as the downstream signaling. Effects of the compounds were quantified in pharmacological cell assays in the dark and using UV and green light illumination. We finally develop a framework for image-based kinetic analysis of GPCRs which allowed us to measure activation kinetics of several prototypical class A GPCRs and to discover membrane heterogeneities of GPCR activation. It appears that GPCR activation signal is not only dependent on the amount of activated receptors, but also has some level of correlation with the local density of activated receptors.